2309 Phase I dose-finding study of S-1 in combination with docetaxel and oxaliplatin (DOS2w) administered every second week in patients with advanced gastro-esophageal cancer von Schoennemann, K.R, Vestermark, L.W, Jensen A, H, Bjerregaard K, J, Krogh, M, Qvortrup, C, Tarpgaard S, L, Ejlsmark, M.W, Pfeiffer, P

Volltext